CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (216,459)	$ (120,097)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	17,221	17,004
Stock-based compensation	33,902	1,457
Change in fair value of warrant liability	2,596	69,294
Telematics devices unreturned	2,084	682
Amortization of debt issuance costs	11,695	687
Noncash interest and other expense	4,701	1,136
Changes in operating assets and liabilities:
Premiums receivable	(510)	273
Accounts receivable	4,496	591
Reinsurance recoverable on paid loss	8,475	4,066
Reinsurance recoverable on unpaid loss	33,941	(5,104)
Prepaid reinsurance premium	13,668	(764)
Prepaid expenses and other assets	2,433	2,920
Deferred transaction costs	3,581	(3,581)
Deferred policy acquisition costs, net	(2,110)	(976)
Digital assets, net	(986)	0
Accounts payable and accrued expenses	2,643	2,119
Ceded reinsurance premium payable	(27,000)	(9,864)
Loss and loss adjustment expense reserves	16,345	4,871
Payable to carriers - premiums and LAE, net	(509)	(1,704)
Unearned premium reserve	(344)	899
Deferred revenue	(216)	617
Deferred tax liability	0	(84)
Other liabilities	(4,769)	3,365
Net cash used in operating activities	(95,122)	(32,193)
Cash flows from investing activities:
Purchases of telematics devices, improvements, and equipment	(7,545)	(6,903)
Payments relating to capitalized website and software development costs	(19,269)	(13,333)
Net change in payable/(receivable) for securities	422	225
Purchase of securities	(63,960)	(26,646)
Sales and maturities of marketable securities	25,587	48,462
Net cash (used in) provided by investing activities	(64,765)	1,805
Cash flow from financing activities:
Proceeds from notes payable	2,015	37,480
Payment on notes payable	(69,351)	0
Proceeds from merger with INSU II, net of issuance costs	336,469	0
Proceeds from exercise of common stock options and warrants	4,387	209
Net cash provided by financing activities	273,520	37,689
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents	113,633	7,301
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	50,188	42,887
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	163,821	50,188
Supplemental cash flow data:
Cash paid for interest	3,164	2,797
Non-cash investing and financing transactions:
Warrants assumed from Business Combination	45,516	0
Net exercise of preferred stock warrants	56,160	0
Net exercise of promissory note	415	0
Capitalized website and software development costs included in accrued liabilities	439	0
Capitalized stock-based compensation	2,316	522
Reclassification of liability to equity for vesting of stock options	169	0
Preferred stock warrant issued in conjunction with note payable	$ 0	$ 12,620